Navigation Links
AcelRx Pharmaceuticals Reports Third Quarter 2012 Financial Results
Date:11/6/2012

REDWOOD CITY, Calif., Nov. 6, 2012 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported financial results for the three and nine months ended September 30, 2012 and provided a corporate update.

Net loss for the third quarter of 2012 was $8.6 million, or $0.38 per share, compared with a net loss of $5.8 million, or $0.30 per share, for the third quarter of 2011.  During the third quarter of 2012, AcelRx recognized revenue of $166,000 resulting from reimbursement for work completed under a research grant from the U.S. Army Medical Research and Materiel Command, or USAMRMC, for development of its ARX-04 product candidate, a single dose Sufentanil NanoTab® for the treatment of moderate-to-severe acute pain. 

Research and development expenses for the third quarter totaled $6.9 million, compared with $3.9 million for the quarter ended September 30, 2011.  The increase was primarily due to expenditures associated with three ongoing Phase 3 studies for ARX-01, the Sufentanil NanoTab PCA System, AcelRx's lead product candidate for the treatment of post-operative pain.  General and administrative expenses were $1.4 million for the quarter ended September 30, 2012, compared with $1.9 million for the third quarter of 2011.  This decrease resulted primarily from lower intellectual property and market research expenses.

For the nine months ended September 30, 2012, AcelRx reported a net loss of $22.8 million, or $1.09 per share, compared with a net loss of $13.7 million, or $0.83 per share, for the same period in 2011.  As of September 30, 2012, AcelRx had cash, cash equivalents and investments of $23.4 million, compared to $31.9 million at June
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. AcelRx Pharmaceuticals Doses the First Patients in ARX-04 Phase 2 Clinical Study
2. AcelRx Pharmaceuticals to Hold Third Quarter 2012 Financial Results Conference Call and Webcast on November 6, 2012
3. AcelRx Pharmaceuticals Hires Mike A. Royal, M.D. as Chief, Clinical Affairs
4. AcelRx Pharmaceuticals to Present at the UBS Global Life Sciences Conference
5. AcelRx Pharmaceuticals Receives Fourth and Fifth U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
6. AcelRx Pharmaceuticals to Present at Three Upcoming Investor Conferences
7. AcelRx Pharmaceuticals Reports Second Quarter 2012 Financial Results
8. AcelRx Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Healthcare Conference
9. AcelRx Pharmaceuticals to Hold Second Quarter 2012 Financial Results Conference Call and Webcast on August 9, 2012
10. AcelRx Pharmaceuticals Receives Two Additional U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
11. AcelRx Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Inc., a medical device company focused on the development ... disease, today announced Retired Congressman Norman Dicks ... in the company,s mission to treat vision impairment. ... Representative for Washington,s 6th congressional ... member of the Democratic Party. His district was located ...
(Date:5/6/2015)... DUBLIN , May 05, 2015 Research ... announced the addition of the "Chromatography (Instruments ... report to their offering. Chromatography ... and identifying the component of a complex mixture ... Over the decades the scientists have considered chromatography ...
(Date:5/6/2015)... DUBLIN , May 06, 2015 Research and Markets ... the "Energy based Ablation Devices - Global Strategic Business ... provides separate comprehensive analytics for the US, Canada ... , Asia-Pacific , and Rest of ... 2014 through 2020. Also, a seven-year historic analysis is provided ...
Breaking Medicine Technology:Retired Congressman Norman Dicks Joins LumiThera's Advisory Team 2Global Chromatography (Instruments and Reagents) Market 2015 - Forecasts to 2019 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 3
... , BEDFORD, Mass., Nov. 25 Hologic, Inc. (Hologic ... manufacturer and supplier of premium diagnostics, medical imaging systems and ... is using the annual meeting of the Radiological Society of ... through December 3, 2009 to highlight our new SecurView(®) DX ...
... 25 BioTrends Research Group, Inc. released Wave 1 of ... report, the first in a multi-phase syndicated market research ... launch through the first six months of availability. Each ... Dermatologists and qualitative information from a subset of 20. ...
Cached Medicine Technology:New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 4Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2
(Date:5/6/2015)... San Francisco, CA (PRWEB) May 06, 2015 ... startup accelerator program - today announced the latest lineup ... Global Innovation Summit . The invitation-only event, scheduled for ... group of senior care executives, consumer technology leaders, investors ... to discuss emerging trends, cultivate partnerships and discover new ...
(Date:5/6/2015)... Houston, TX (PRWEB) May 06, 2015 ... focuses on wellness for the estimated 46 million Americans ... disease rely upon monthly medications to alleviate their symptoms. ... card to save patients money on the costs ... , NSAIDS are used to treat the pain and ...
(Date:5/6/2015)... Wethersfield, Conn. (PRWEB) May 06, 2015 ... company in Wethersfield, Conn., has hired healthcare executive ... vice president. Olson will lead Qualidigm’s growing ... further Qualidigm’s mission to improve the quality, safety, ... Olson comes to Qualidigm from Interim HealthCare of ...
(Date:5/6/2015)... 2015 The Center for Innovative Technology ... invested in e-Kare, Inc. of Fairfax, VA, a digital ... of chronic wounds. , Chronic wounds include pressure, venous, ... that affect over 6.5 million U.S. patients, costing over ... enterprise from the Children’s National Medical Center (CNMC), ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 ProTrailer Cartoon ... fun self-animating generators for Final Cut Pro X ... stylistic titles to a Final Cut Pro X project.It ... professional quality openers to any shot has never been ... level in mind, saving users time while adding amazing ...
Breaking Medicine News(10 mins):Health News:Aging2.0 Global Innovation Summit Provides Unique Forum to Discover New Technologies and Develop Partnerships in the Senior Care Market 2Health News:Aging2.0 Global Innovation Summit Provides Unique Forum to Discover New Technologies and Develop Partnerships in the Senior Care Market 3Health News:Aging2.0 Global Innovation Summit Provides Unique Forum to Discover New Technologies and Develop Partnerships in the Senior Care Market 4Health News:Medicationdiscountcard.com Provides Access to Drug Coupons for Arthritis Awareness Month 2Health News:Medicationdiscountcard.com Provides Access to Drug Coupons for Arthritis Awareness Month 3Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 2Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 3Health News:CIT GAP Funds Invests in e-Kare 2Health News:CIT GAP Funds Invests in e-Kare 3Health News:Pixel Film Studios announces the release of Protrailer Cartoon Volume 2 for Final Cut Pro X. 2
... Joint collaboration will bring alternative herbicide tolerant systems and ... more choice for farmers ... Bayer CropScience AG, Mertec,LLC and M.S. Technologies LLC announced ... to jointly develop and commercialize,several innovative trait technology products ...
... therapies that are not the best for them, study ... than a third of prostate cancer patients may receive ... already having with urinary, bowel or sexual function, a ... patients don,t give enough information to their doctor or ...
... how they ,Think About Their Drink, SOUTH BEND, Ind., Nov. 26 , ... the Think About Your Drink Family ... WHAT: The Adams family entered the photo contest by submitting a ... milk. As part of a ...
... COM, VANCOUVER, Nov. 26 /PRNewswire-FirstCall/ - Cardiome Pharma ... for expected,interim results from its Phase 2b clinical trial ... disclose the interim,analysis in the fourth quarter of 2007. ... analysis in March 2008, with the final study,results to ...
... cancer patients often receive treatment that is contraindicated ... according to a new study. Dr. James Talcott ... co-investigators found that patients with certain pretreatment dysfunctions ... lead to worse outcomes. The study is published ...
... Suzanne Smalley looks at,GOP presidential candidate Rudy Giuliani,s background ... once rigid (in public) and flexible (in,private life). The ... back to his childhood and youth in New York ... hoods and to a Catholic culture with a,strict moral ...
Cached Medicine News:Health News:Bayer CropScience, Mertec and M.S. Technologies to Co-Develop New Soybean Trait Products 2Health News:Bayer CropScience, Mertec and M.S. Technologies to Co-Develop New Soybean Trait Products 3Health News:Prostate Cancer Treatments Often Compound Existing Health Problems 2Health News:Prostate Cancer Treatments Often Compound Existing Health Problems 3Health News:Prostate Cancer Treatments Often Compound Existing Health Problems 4Health News:South Bend Area Family Wins Nationwide got milk? Contest 2Health News:South Bend Area Family Wins Nationwide got milk? Contest 3Health News:Cardiome Updates Guidance 2Health News:Cardiome Updates Guidance 3Health News:Cardiome Updates Guidance 4Health News:Many prostate cancer patients receive improper or 'mismatched' therapies 2Health News:NEWSWEEK: Media Lead Sheet/December 3, 2007 Issue (on newsstands Monday, November 26). 2Health News:NEWSWEEK: Media Lead Sheet/December 3, 2007 Issue (on newsstands Monday, November 26). 3Health News:NEWSWEEK: Media Lead Sheet/December 3, 2007 Issue (on newsstands Monday, November 26). 4
... BALLARD Adult TRACH CARE Double Swivel ... patients. Dual swivels provide flexibility without ... and tactile sleeve for better feel. ... the distance of catheter advance. Offers ...
... KIMBERLY-CLARK BALLARD Adult ... designed for endotracheal intubated ... Features clear T-Piece, lavage/irrigation ... port. Offers multiple tracheostomy ...
... Our soft, flexible whistle tip suction ... kit that includes: One pair of ... 120 ml bottle of sterile saline. ... use with cuffed gloves and catheter ...
... Irri-Cath® catheters help decrease the need ... alternative to fiber-optic bronchoscope for bronchial ... in opportunistic infections., ,All Portex® ... ,The Irri-Cath® suction system ...
Medicine Products: